April 2022 updates to the website

The website has now been updated following April's LSCMMG

The following medicines have been added/updated:

Bempedoic acid with ezetimibe - updated background info

The following Items will be updated and added to the website following the next Strategic Commissioning Committee (SCC) Meeting:

Empagliflozin - For treating chronic heart failure with reduced ejection fraction (NICE TA773)

Dapagliflozin - For treating chronic kidney disease (NICE 775)

Ozurdex (dexamethasone intravitreal implant) - for adult patients who have visual impairment due to diabetic macular oedema (DME) who are not pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy

Trimbow NEXThaler - COPD